ATI RN
Basic Principles of Pharmacology Quizlet Questions
Question 1 of 5
Sympathetic and parasympathetic preganglionic neurons are cholinergic. What neurotransmitter do they release at the synapse in the ganglion?
Correct Answer: D
Rationale: Step 1: Sympathetic and parasympathetic preganglionic neurons are cholinergic, meaning they release acetylcholine. Step 2: In the autonomic nervous system, preganglionic neurons synapse with postganglionic neurons in ganglia. Step 3: Since preganglionic neurons release acetylcholine, they will also release acetylcholine at the synapse in the ganglion. Summary: - Dopamine, serotonin, and GABA are not typically released by sympathetic and parasympathetic preganglionic neurons. - Acetylcholine is the primary neurotransmitter released by cholinergic neurons in the autonomic nervous system, making it the correct choice.
Question 2 of 5
Drugs with a very large volume of distribution (Vd) would be confined to
Correct Answer: B
Rationale: The correct answer is B: Fatty tissue. Drugs with a large volume of distribution (Vd) distribute extensively into tissues, especially those with high lipid content like fatty tissue. Lipophilic drugs tend to accumulate in fatty tissues due to their high lipid solubility. This leads to a higher volume of distribution as the drug is not primarily confined to the blood but distributed into tissues. Choices A, C, and D are incorrect because drugs with a large Vd are not typically confined to the GI tract, interstitial tissue, or intravascular fluid, as they distribute widely throughout the body.
Question 3 of 5
Competitive antagonists compete for the same agonist binding site. This is likely to
Correct Answer: C
Rationale: The correct answer is C because competitive antagonists compete with the agonist for the same binding site, leading to a decrease in the potency of the drug. This occurs because the antagonist reduces the number of available binding sites for the agonist, requiring a higher concentration of the agonist to achieve the same effect. Option A is incorrect as efficacy is related to the maximal effect of a drug, not affected by competitive antagonists. Option B is incorrect because a leftward shift in the dose-response curve indicates an increase in potency, which is not the case with competitive antagonists. Option D is incorrect because competitive antagonists do affect the agonist dose-response curve by reducing potency.
Question 4 of 5
A 22-year-old woman suffering from asthma was prescribed albuterol by inhalation. Albuterol is a bronchodilating drug with a molecular weight of 239 daltons. Which of the following permeation processes most likely accounted for the transfer of the drug through the bronchial mucosa?
Correct Answer: C
Rationale: Facilitated diffusion is the most likely permeation process for the transfer of albuterol through the bronchial mucosa. This process involves the use of carrier proteins to facilitate the movement of molecules across the membrane. Since albuterol is a relatively small molecule with a molecular weight of 239 daltons, it is more likely to utilize facilitated diffusion rather than bulk flow transport, endocytosis, or active transport. Lipid diffusion is not as efficient for larger molecules like albuterol, making facilitated diffusion the most suitable choice for this scenario.
Question 5 of 5
Which of the following features best explains why formulation W produces the largest plasma concentration-time curve of the drug?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.